Latest filing published 08 Apr 2026 for Zai Lab Ltd, €49k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Rafael Amado discloses dealings in 3 companies, chiefly Zai Lab Ltd, Allogene Therapeutics, Inc. and Poseida Therapeutics, Inc. In total, 31 filings cover trades dated from 18 May 2021 to 6 April 2026.
No open-market purchase appears, only 13 sales worth €1.1M. Besides market trades, the filings include 8 share grants and 9 option exercises. Since January 2026: no purchases and 3 sales on the market.
The latest filing, published on 8 April 2026, reports an open-market sale of €49k in Zai Lab Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations